Cristina Ramona Cudalbu MoldovanCristina Cudalbu obtained her Bachelors of Science degree in Medical Physics in 2002 and Masters of Science degree in Biophysics and Medical Physics in 2003, both from University Babes-Bolyai, Cluj-Napoca, Romania. In 2006 she obtained her PhD degree in Localized Proton MRS and time domain quantification of cerebral metabolites at 7T and 4.7T at University Lyon 1, RMN Laboratory, Villeurbanne, France.In 2007, she joined, as a Scientist, the Laboratory for Functional and Metabolic Imaging at EPFL, where she implemented new acquisition and quantification techniques for in vivo nitrogen, proton and carbon MRS for preclinical studies. Starting 2012, Cristina Cudalbu was appointed as Research Staff Scientist and 9.4T MRI Operational Manager at Centre d’Imagerie Biomédicale (CIBM) at EPFL. She is now developing new research lines at CIBM, being oriented towards new acquisition and quantification techniques for in vivo proton, phosphorous, carbon, nitrogen MRS and fast MRSI, diffusion weighted spectroscopy and brain macromolecules quantification. She is now applying these developments on chronic hepatic encephalopathy, a research area that she developed at CIBM (https://actu.epfl.ch/news/when-liver-disease-affects-the-brain/), and on different collaborative projects with researchers from the five partner institutions of CIBM. Jean-Marc OdobezExpertise
Computer Vision, machine Learning (Bayesian models, deep learning), multimodal processing.Activity analysis, human behavior understanding, human communication, interaction modeling
Dr Jean-Marc Odobez (Msc 1990, PhD 1994) received his Ph.D degree from Rennes University in 1994 for his PhD dissertation done at INRIA. After 5 years as an assistant professor at the University du Maine, France, he decided to join Idiap, where he is now the Head of the Perception & Activity Understanding Group and adju
Angela Ingrid RentonExpertise
Visual perceptionAttentionPredictionDecision-makingM/EEGClosed-loop neuroimagingOpen & reproducible science
Mission
Angela Renton completed her PhD in 2022 at under the supervision of Prof. Jason Mattingley, at The University of Queensland, Australia. Her PhD investigated the development of novel neurofeedback and closed-loop research methods to causally investigate the neural mechanisms of visual perception. As a postdoctoral research fellow, she has expanded on this work, working on real-time ne
Graham KnottGraham Knott received his degree in physiology from the University of Southampton, UK, in 1990, and his PhD in neuroscience from the University of Tasmania, Australia, in 1995. He moved to the University of Lausanne in Switzerland in 1999 where he researched the plasticity of neuronal connectivity in the adult brain, developing correlative light and electron microscopy methods for the analysis of in vivo imaged neurons. In 2006 Graham joined the Ecole Polytechnique Fédérale de Lausanne, establishing the Bio Electron Microscopy Facility and has continued his research interests in brain plasticity and 3D electron microscopy.
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Simone AstoriTeaching & PhD Past EPFL PhD Students as codirector Silvia Monari, Alessandro Chioino, Loredana Cumpana
Mathieu SalzmannI am a Senior Researcher at EPFL-CVLab, and, since May 2020, an Artificial Intelligence Engineer at ClearSpace (50%). Previously, I was a Senior Researcher and Research Leader in NICTA's computer vision research group. Prior to this, from Sept. 2010 to Jan 2012, I was a Research Assistant Professor at TTI-Chicago, and, from Feb. 2009 to Aug. 2010, a postdoctoral fellow at ICSI and EECS at UC Berkeley under the supervision of Prof. Trevor Darrell. I obtained my PhD in Jan. 2009 from EPFL under the supervision of Prof. Pascal Fua.
Alexandre TerrierExpertise
BiomechanicsJoint biomechanicsMecano-biologyOrthopaedic researchPatient-specific modellingContinuum mechanicsFinite Element AnalysisExperimental testingStatistical analyses
Expertise
BiomechanicsJoint biomechanicsMecano-biologyOrthopaedic researchPatient-specific modellingContinuum mechanicsFinite Element AnalysisExperimental testingStatistical analyses
Mission
Develop patient-specific models of human joints and their replacement, in parallel with a database of patients, in order to test statistic
Show more